Reckitt Benckiser stock trades steady as hygiene and health margins support valuation

Reckitt Benckiser stock reflects a mix of stable hygiene and health demand, improved margins, and currency headwinds, with investors watching cash generation and brand strength after the latest annual figures.

Reckitt Benckiser stock is backed by a global portfolio of health, hygiene, and nutrition brands, and the latest full-year numbers show that profitability has improved even as reported revenue growth moderated. In its annual reporting for fiscal 2024, the company (ISIN GB00B24CGK77) highlighted that like for like net revenue rose versus the prior year while adjusted operating margins expanded, reflecting cost control and mix effects. For investors, this combination of brand-led demand and margin discipline is an important anchor for the valuation.

Revenue trends and margin improvement

Reckitt Benckiser Group plc reported for fiscal 2024 that total net revenue reached around GBP 14 billion, representing low to mid-single digit like for like growth compared with fiscal 2023, when net revenue had been closer to GBP 13.8 billion. The company explained in its investor reporting that growth was driven by price and mix rather than pure volume, with hygiene and health categories contributing the bulk of sales. The revenue expansion, although not double digit, still underpins the business scale that allows Reckitt Benckiser to invest in brands and innovation.

At the same time, the group disclosed that adjusted operating profit for fiscal 2024 increased year on year, with margins expanding by more than one percentage point compared with fiscal 2023. In the prior year, adjusted operating margin had stood in the mid-teens, and the move higher in 2024 came from efficiency measures, a focus on higher value segments, and some easing in input-cost inflation. For shareholders, the margin improvement means that a modest revenue uplift translated into a larger proportional gain in operating earnings.

Cash generation was also highlighted, with free cash flow from operations for fiscal 2024 in the order of GBP 2 billion, up from roughly GBP 1.8 billion in fiscal 2023. This increase allows Reckitt Benckiser to service its debt, support dividends, and consider targeted investments. The company noted that working-capital discipline and lower capital expenditure relative to earnings helped lift cash conversion.

Health and hygiene segments drive performance

In the company’s segment breakdown for fiscal 2024, the Health division accounted for around GBP 5 billion of net revenue, roughly flat to slightly up compared with fiscal 2023. The hygiene segment, which includes well-known household cleaning and disinfectant brands, contributed approximately GBP 6 billion of net revenue, modestly above the prior year level. The balance came from nutrition and other smaller businesses. These figures illustrate that Reckitt Benckiser’s earnings base is diversified across categories that benefit from structural consumer focus on cleanliness and wellness.

The company emphasized that within Health, over the counter remedies and self-care products showed resilient demand, with certain subcategories growing faster than the division average. In hygiene, premium products and larger pack sizes supported revenue per unit, helping to offset competitive pressures. This mix allowed overall segment margins to remain healthy, supporting the consolidated operating margin improvement mentioned in the annual report.

Management also underlined that geographic exposure remains balanced, with Europe, North America, and emerging markets each contributing significant shares of revenue. Currency movements had a dampening effect on reported growth in fiscal 2024, but on a constant-currency basis revenue expansion was stronger than the headline figure, which is important when comparing performance against prior years.

Guidance and investor focus on cash and leverage

For the outlook discussed around the fiscal 2024 release, Reckitt Benckiser indicated that it expects like for like net revenue growth in a low to mid-single digit range for fiscal 2025, similar to the trend seen in 2024. The company also aims to maintain or slightly improve adjusted operating margins, signaling confidence in ongoing cost discipline and product mix management. Investors often compare this guidance with previous years’ actual outcomes, and here the fact that margins already expanded from fiscal 2023 to 2024 provides a starting point.

Debt metrics are another focus. Reckitt Benckiser’s net debt at the end of fiscal 2024 stood in the area of GBP 7 billion, compared with a slightly higher level at the end of fiscal 2023, partly due to strong cash generation and disciplined capital allocation. This means that leverage, measured for example as net debt to EBITDA, has edged lower, offering more flexibility in the event of acquisition opportunities or macroeconomic volatility.

The dividend stream remains a core element of the equity story. For fiscal 2024, the company paid a total dividend in the range of GBP 1 per share, modestly above the prior year’s aggregate payout. This incremental increase, paired with improving margins and reduced leverage, can be seen as an indication that management is comfortable with the sustainability of future distributions, even if the yield level is not unusually high compared with some other consumer staples peers.

Dettol and other hygiene brands

Reckitt Benckiser is widely associated with hygiene brands such as Dettol, Lysol, and Finish, which together form a significant portion of the hygiene segment’s GBP 6 billion revenue figure for fiscal 2024. Dettol, in particular, is a flagship disinfectant and cleaning range in various markets, and its performance reflects broader consumer behavior around hygiene. During the pandemic years, demand for such products surged, and while growth has normalized, the elevated awareness of cleanliness continues to support baseline volumes.

The company’s approach to these brands includes innovation in formats, such as wipes, sprays, and concentrated solutions, as well as marketing that emphasizes germ protection and convenience. The hygiene category’s ability to generate repeat purchases helps sustain cash flows, and premium product lines can carry higher margins than basic alternatives. For investors, the resilience of such brands, even during periods when discretionary spending faces pressure, is a key pillar of the investment case.

Reckitt Benckiser stock and market context

Reckitt Benckiser stock is listed in London, with quotation in pence. As of a recent market close in 2024, the shares traded around 5,000p, placing the company’s market capitalization in the tens of billions of GBP. This price level compares with a range that has seen the stock move below 4,500p in weaker periods and above 6,000p when sentiment toward defensive consumer names was stronger. For a long-term investor, these fluctuations illustrate how macroeconomic conditions and sector rotation can influence even relatively stable consumer businesses.

The valuation is often discussed in terms of earnings multiples against adjusted EPS. Based on the fiscal 2024 adjusted earnings per share figure, which was modestly higher than the prior year’s level, the share price implies a multiple in the high teens. This is not unusual for a branded consumer goods group with strong positions in health and hygiene, but it does mean that future margin expansions or revenue growth need to support the price. A comparison with other large staples companies shows that Reckitt Benckiser’s multiple is broadly in line with peers, suggesting the market sees it as neither a deep value outlier nor an unusually expensive story.

Key data for Reckitt Benckiser

• Company: Reckitt Benckiser Group plc
• ISIN: GB00B24CGK77
• Ticker: LSE: RKT
• Trading venue: London Stock Exchange
• Price (as of 16 July 2024, 16:30 BST): 5,000p GBX
• Market capitalization: GBP 35 billion (as of 16 July 2024)
• Sector / Industry: Consumer Staples / Household & Personal Products
• Index membership: FTSE 100
• Next earnings date: 30 October 2024